199 related articles for article (PubMed ID: 36050418)
21. Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in paraneoplastic encephalitis.
Popkirov S; Ayzenberg I; Hahn S; Bauer J; Denno Y; Rieckhoff N; Radzimski C; Hans VH; Berg S; Roghmann F; Noldus J; Bien CG; Skodda S; Wellmer J; Stöcker W; Krogias C; Gold R; Schlegel U; Probst C; Komorowski L; Miske R; Kleiter I
Acta Neuropathol Commun; 2017 May; 5(1):40. PubMed ID: 28554330
[TBL] [Abstract][Full Text] [Related]
22. Paraneoplastic encephalitis associated with renal cell carcinoma.
Jang Y; Kim S; Chu K; Lee SK; Lee ST
Encephalitis; 2021 Jul; 1(3):73-78. PubMed ID: 37469845
[TBL] [Abstract][Full Text] [Related]
23. Real-world application of the updated diagnostic criteria for paraneoplastic neurological syndromes.
Campetella L; Papi C; Sabatelli E; Marini S; Iorio R
J Neuroimmunol; 2022 Nov; 372():577972. PubMed ID: 36202000
[TBL] [Abstract][Full Text] [Related]
24. A large screen for paraneoplastic neurological autoantibodies; diagnosis and predictive values.
Seluk L; Taliansky A; Yonath H; Gilburd B; Amital H; Shoenfeld Y; Kivity S
Clin Immunol; 2019 Feb; 199():29-36. PubMed ID: 30543927
[TBL] [Abstract][Full Text] [Related]
25. Autoimmune encephalitis and paraneoplastic syndromes in Turkey: a multi-centre study.
Gozubatik-Celik RG; Gul ZB; Bilgin EB; Yildiz MU; Yenidunya O; Misirli H; Celik HT; Kurtulus F; Yaman A; Domac F; Karaci R; Cokar O; Culha Oktar A; Emre Toprak U; Yavuz N; Dalgıc E; Ozen Barut B; Dogan Ak P; Ozgenc CI; Bulbul NG; Atmaca MM; Gokyigit FM; Gürkan ZM; Pazarci N; Surmeli R; Kale N; Yildirim Z; Yayla V; Sozer N; Cabalar M; Delen F; Ucler S; Unal E; Sungur MA; Sen A; Atakli D; Soysal A
Neurol Sci; 2022 Jul; 43(7):4393-4403. PubMed ID: 35211811
[TBL] [Abstract][Full Text] [Related]
26. Paraneoplastic antibodies targeting intracellular antigens.
Linnoila JJ
Handb Clin Neurol; 2024; 200():335-346. PubMed ID: 38494288
[TBL] [Abstract][Full Text] [Related]
27. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
28. Onconeuronal and antineuronal antibodies in patients with neoplastic and non-neoplastic pulmonary pathologies and suspected for paraneoplastic neurological syndrome.
Michalak S; Cofta S; Piatek A; Rybacka J; Wysocka E; Kozubski W
Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):156-61. PubMed ID: 20156748
[TBL] [Abstract][Full Text] [Related]
29. [Paraneoplastic Neurologic Syndromes].
Tanaka K
Brain Nerve; 2023 Jun; 75(6):755-762. PubMed ID: 37287359
[TBL] [Abstract][Full Text] [Related]
30. [Paraneoplastic neurological syndromes].
Lambert N; Lutteri L; Sadzot B; Maquet P; Moonen G
Rev Med Liege; 2021 May; 76(5-6):413-418. PubMed ID: 34080373
[TBL] [Abstract][Full Text] [Related]
31. Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors.
Antoine JC; Absi L; Honnorat J; Boulesteix JM; de Brouker T; Vial C; Butler M; De Camilli P; Michel D
Arch Neurol; 1999 Feb; 56(2):172-7. PubMed ID: 10025422
[TBL] [Abstract][Full Text] [Related]
32. [Clinical features and treatment of paraneoplastic neurological syndrome associated with small cell lung cancer].
Zhou L; Guan H; Liu H; Zhu Y; Peng B; Li S; Cui L
Zhonghua Yi Xue Za Zhi; 2015 Oct; 95(37):3023-6. PubMed ID: 26814083
[TBL] [Abstract][Full Text] [Related]
33. Paraneoplastic neurological syndromes in patients affected by SCLC: a case series.
Zanella C; Leone AG; Zambelli L; Bottiglieri A; Canziani L; Brambilla M; Lo Russo G; Platania M; De Braud F; Occhipinti M
Tumori; 2022 Dec; 108(6):NP11-NP14. PubMed ID: 35260015
[TBL] [Abstract][Full Text] [Related]
34. Paraneoplastic neurological syndromes.
Graus F; Dalmau J
Curr Opin Neurol; 2012 Dec; 25(6):795-801. PubMed ID: 23041955
[TBL] [Abstract][Full Text] [Related]
35. Autonomic nervous system involvement in autoimmune encephalitis and paraneoplastic neurological syndromes.
Villagrán-García M; Farina A; Campetella L; Arzalluz-Luque J; Honnorat J
Rev Neurol (Paris); 2024; 180(1-2):107-116. PubMed ID: 38142198
[TBL] [Abstract][Full Text] [Related]
36. Paraneoplastic manifestations of renal cell carcinoma.
Gold PJ; Fefer A; Thompson JA
Semin Urol Oncol; 1996 Nov; 14(4):216-22. PubMed ID: 8946620
[TBL] [Abstract][Full Text] [Related]
37. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force.
Vedeler CA; Antoine JC; Giometto B; Graus F; Grisold W; Hart IK; Honnorat J; Sillevis Smitt PA; Verschuuren JJ; Voltz R;
Eur J Neurol; 2006 Jul; 13(7):682-90. PubMed ID: 16834698
[TBL] [Abstract][Full Text] [Related]
38. PET scan in clinically suspected paraneoplastic neurological syndromes: a 6-year prospective study in a regional neuroscience unit.
Hadjivassiliou M; Alder SJ; Van Beek EJ; Hanney MB; Lorenz E; Rao DG; Sharrack B; Tindale WB
Acta Neurol Scand; 2009 Mar; 119(3):186-93. PubMed ID: 18855873
[TBL] [Abstract][Full Text] [Related]
39. [Neurological syndromes, encephalitis].
Yamamoto T; Tsuji S
Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
[TBL] [Abstract][Full Text] [Related]
40. Immunophenotypical characterization of paraneoplastic neurological syndrome patients: a multicentric study.
Lorusso L; Precone V; Hart IK; Giometto B; Pezzani R; Ngonga GK; Ngonga GKNK; Paolacci S; Ferrari D; Ricevuti G; Marshall E; Bertelli M
J Biosci; 2021; 46():. PubMed ID: 33709965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
